Current Drug Therapy of Protozoal Diarrhoea

被引：21

作者：

Gupta Y.K. ^{[1
,4
]}

Gupta M. ^{[2
]}

Aneja S. ^{[3
]}

Kohli K. ^{[2
]}

机构：

[1] Indust. Taxocology Res. Ctr. (ITRC), Lucknow

[2] Department of Pharmacology, Lady Hardinge Medical College, New Delhi

[3] Department of Pediatrics, Kalawati Saran Children's Hospital, Lady Hardinge Medical College, New Delhi

[4] Indust. Taxocology Res. Ctr. (ITRC), Lucknow - 226001, MG Marg

来源：

The Indian Journal of Pediatrics | 2004年 / 71卷 / 1期

关键词：

Amoebiasis; Diarrhoea; Giardiasis; Metronidazole; Protozoa; Tinidazole;

D O I：

10.1007/BF02725657

中图分类号：

学科分类号：

摘要：

Protozoal infections of the gastrointestinal tract occur worldwide and have substantial morbidity and mortality. Prevalence is higher in the economically deprived regions of the world, especially the developing countries. Infections like amoebiasis and giardiasis have a worldwide distribution, being endemic in India. Apart from producing GI symptoms, growth and development of children is also impaired. It is seen that protozoa multiply rapidly in their hosts and as there is a lack of effective vaccines, chemotherapy has been the only practiced way to treat individuals and reduce transmission. The current treatment modalities for protozoal diarrhoea include 5-nitrosoimidazoles, iodoquinol, diloxanide furoate, paromomycin, chloroquine, and trimethoprim-sulphamethoxazole.

引用

页码：55 / 58

页数：3

共 14 条

[1]

Lo C.W., Walker W.A., Chronic protracted diarrhoea of infancy: A nutritional disease, Pediatrics, 72, 6, pp. 786-800, (1983)

[2]

Mathur R., Reddy V., ORS and bacterial contamination, Nutritional News, 4, 6, pp. 1-2, (1983)

[3]

Freeman C.D., Klutman N.E., Lamp K.C., Metronidazole. A therapeutic review and update, Drugs, 54, pp. 679-708, (1997)

[4]

Amoebiasis, Wkly Epidemiol Rec, 14, pp. 97-99, (1997)

[5]

Reed S.L., Harrison's Principles of Internal Medicine, pp. 1176-1180

[6]

Ortiz J.J., Ayoub A., Gargala G., Et al., Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru, Aliment Pharmacol Ther, 15, pp. 1409-1415, (2001)

[7]

Nash T.E., Ohl C.A., Thomas E., Et al., Treatment of patients with refractory giardiasis, Clin Infect Dis, 33, pp. 22-28, (2001)

[8]

Wolfe M.S., Giardiasis, Clin Microbiol Rev, 5, pp. 93-100, (1992)

[9]

Rossignol J.A., Ayoub A., Ayers M.S., Treatment of diarrhea caused by Cryptosporidium parvum: A prospective randomized, double-blind, placebo-controlled study of Nitazoxanide, J Infect Dis, 184, pp. 103-106, (2001)

[10]

Schuster H., Chiodini P.L., Parasitic infections of the intestine, Curr Opin Infect Dis, 14, 5, pp. 587-591, (2001)

← 1 2 →